Search Results - "Lucero, Olivia M"

The V-ATPase B1-subunit promoter drives expression of Cre recombinase in intercalated cells of the kidney by Miller, R. Lance, Lucero, Olivia M., Riemondy, Kent A., Baumgartner, Brett K., Brown, Dennis, Breton, Sylvie, Nelson, Raoul D.

“…The collecting duct of the kidney is composed of two morphologically and physiologically distinct cell types, principal and intercalated cells. To better…”
Get full text

Identification, genetic testing, and management of hereditary melanoma by Leachman, Sancy A., Lucero, Olivia M., Sampson, Jone E., Cassidy, Pamela, Bruno, William, Queirolo, Paola, Ghiorzo, Paola

“…Several distinct melanoma syndromes have been defined, and genetic tests are available for the associated causative genes. Guidelines for melanoma genetic…”
Get full text

Phenotype switch in acute lymphoblastic leukaemia associated with 3 years of persistent CAR T cell directed‐CD19 selective pressure by Lucero, Olivia M., Parker, Kellee, Funk, Tracy, Dunlap, Jennifer, Press, Richard, Gardner, Rebecca A., Chang, Bill H.

Get full text

Tranexamic Acid Prevention of Hemorrhagic Complications Following Interpolated Flap Repair: A Single-Center, Retrospective, Cohort Study by Freeman, S. Caleb, Heath, Michael S., Neill, Brett, Morris, Caroline, Lucero, Olivia M., Yu, Wesley, Bar, Anna, Leitenberger, Justin J.

“…Tranexamic acid (TXA) is increasingly being used to prevent hemorrhagic complications after dermatologic surgery. Interpolated flap repairs following Mohs…”
Get full text

Patient-Specific Targeting of the T-Cell Receptor Variable Region as a Therapeutic Strategy in Clonal T-Cell Diseases by Lucero, Olivia M, Lee, Ji-Ann, Bowman, Jenna, Johnson, Kara, Sapparapu, Gopal, Thomas, John K, Fan, Guang, Chang, Bill H, Thiel-Klare, Karina, Eide, Christopher A, Okada, Craig, Palazzolo, Mike, Lind, Evan, Kosaka, Yoko, Druker, Brian J, Lydon, Nicholas, Bowers, Peter M

“…Targeted therapeutics are a goal of medicine. Methods for targeting T-cell lymphoma lack specificity for the malignant cell, leading to elimination of healthy…”
Get full text

Quinacrine-Associated Punctate Palmar Keratoderma by Haag, Carter, Lucero, Olivia M., Fett, Nicole M.

Get full text

Single-Cell Identification of Melanoma Biomarkers in Circulating Tumor Cells by Fankhauser, Reilly, Chang, Matthew, Garrison, Zachary, Berryman, Rachel, Lucero, Olivia M, Fuiten, Allison, DePatie, Nicholas, Seifert, Hilary, Kulkarni, Rajan P

“…The current standard for investigating tumors is surgical biopsy, which is costly, invasive, and difficult to perform serially. As an adjunct, circulating…”
Get full text

A Re-evaluation of the “Oncogenic” Nature of Wnt/β-catenin Signaling in Melanoma and Other Cancers by Lucero, Olivia M., Dawson, David W., Moon, Randall T., Chien, Andy J.

“…In cancer, Wnt/β-catenin signaling is ubiquitously referred to as an “oncogenic” pathway that promotes tumor progression. This review examines how the…”
Get full text

A case illustrating successful eradication of recurrent, aggressive basal cell carcinoma located in a scar with vismodegib by Lucero, Olivia M, Fitzmaurice, Sarah, Thompson, Curtis, Leitenberge, Justin

“…Vismodegib is a small molecule inhibitor of the Hedgehog signaling pathway that has shown efficacy in the control of locally advanced or metastatic basal cell…”
Get full text

WNT5A enhances resistance of melanoma cells to targeted BRAF inhibitors by Anastas, Jamie N, Kulikauskas, Rima M, Tamir, Tigist, Rizos, Helen, Long, Georgina V, von Euw, Erika M, Yang, Pei-Tzu, Chen, Hsiao-Wang, Haydu, Lauren, Toroni, Rachel A, Lucero, Olivia M, Chien, Andy J, Moon, Randall T

“…About half of all melanomas harbor a mutation that results in a constitutively active BRAF kinase mutant (BRAF(V600E/K)) that can be selectively inhibited by…”
Get full text

Functional genomic analysis identifies drug targetable pathways in invasive and metastatic cutaneous squamous cell carcinoma by Anderson, Ashley N, McClanahan, Danielle, Jacobs, James, Jeng, Sophia, Vigoda, Myles, Blucher, Aurora S, Zheng, Christina, Yoo, Yeon Jung, Hale, Carolyn, Ouyang, Xiaoming, Clayburgh, Daniel, Andersen, Peter, Tyner, Jeffrey W, Bar, Anna, Lucero, Olivia M, Leitenberger, Justin J, McWeeney, Shannon K, Kulesz-Martin, Molly

“…Although cutaneous squamous cell carcinoma (cSCC) is treatable in the majority of cases, deadly invasive and metastatic cases do occur. To date there are…”
Get full text

Keratinocyte carcinomas arising near arteriovenous fistulas: Case series and safety considerations for dermatologic surgery: A report of the International Transplant Skin Cancer Collaborative by Lucero, Olivia M, Echaiz, Claudia Flores, Jafarian, Fatemeh, Fox, Matthew C, Vetto, John T, Mueller, Reid V, Teixeira, Pedro G, Zwald, Fiona O, Leitenberger, Justin J

Get full text

CAR-NK Specific Targeting of Clonal Tcrvβ Chain to Treat T-Cell Non-Hodgkin's Lymphoma by Morris, Karen E, Bowman, Jenna, Lee, Ji-Ann, Tyner, Jeffrey W, Palazzolo, Mike, Druker, Brian J., Lydon, Nick, Bowers, Peter M, Lucero, Olivia M

“…Background T-cell Non-Hodgkin Lymphoma (T-NHL) is a diverse group of aggressive malignancies which are minimally researched and have poorer patient outcomes…”
Get full text

Phenotype switch in acute lymphoblastic leukaemia associated with 3 years of persistent CAR T cell directed‐ CD 19 selective pressure by Lucero, Olivia M., Parker, Kellee, Funk, Tracy, Dunlap, Jennifer, Press, Richard, Gardner, Rebecca A., Chang, Bill H.

Get full text

Quinacrine-Associated Punctate Palmar Keratoderma by Haag, Carter, Lucero, Olivia M., Fett, Nicole M.

Get full text

Abstract P32: CAR-NK Specific Targeting of Clonal TCRVβ Chain to Treat T-cell Non-Hodgkin's Lymphoma by Morris, Karen E, Bowman, Jenna, Lee, Ji-Ann, Tyner, Jeffrey, Palazzolo, Mike, Druker, Brian J, Lydon, Nick, Bowers, Peter M, Lucero, Olivia M

“…T-cell Non-Hodgkin Lymphoma (T-NHL) is a diverse group of aggressive malignancies. Therapies are characterized by pan T-cell cytotoxicity, poor response rates,…”
Get full text

Wnt/β-catenin signaling and AXIN1 regulate apoptosis triggered by inhibition of the mutant kinase BRAFV600E in human melanoma by Biechele, Travis L, Kulikauskas, Rima M, Toroni, Rachel A, Lucero, Olivia M, Swift, Reyna D, James, Richard G, Robin, Nick C, Dawson, David W, Moon, Randall T, Chien, Andy J

“…Because the Wnt/β-catenin signaling pathway is linked to melanoma pathogenesis and to patient survival, we conducted a kinome small interfering RNA (siRNA)…”
Get more information

Keratinocyte carcinomas arising near arteriovenous fistulas: Case series and safety considerations for dermatologic surgery by Lucero, Olivia M., Echaiz, Claudia Flores, Jafarian, Fatemeh, Fox, Matthew C., Vetto, John T., Mueller, Reid V., Teixeira, Pedro G., Zwald, Fiona O., Leitenberger, Justin J.

Get full text

Phenotype switch in acute lymphoblastic leukaemia associated with 3 years of persistent CAR T cell directed-CD19 selective pressure by Lucero, Olivia M, Parker, Kellee, Funk, Tracy, Dunlap, Jennifer, Press, Richard, Gardner, Rebecca A, Chang, Bill H

Get full text

Keratinocyte carcinomas arising near arteriovenous fistulas: Case series and safety considerations for dermatologic surgery: A report of the International Transplant Skin Cancer Collaborative by Lucero, Olivia M, Echaiz, Claudia Flores, Jafarian, Fatemeh, Fox, Matthew C, Vetto, John T, Mueller, Reid V, Teixeira, Pedro G, Zwald, Fiona O, Leitenberger, Justin J

Get full text